Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Fighting the IBB Trend
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by springisnearon Feb 02, 2016 4:46pm
104 Views
Post# 24517869

RE:RE:RE:Fighting the IBB Trend

RE:RE:RE:Fighting the IBB Trendwhat you need to realize here is that CXR does NOT price gouge and will benefit greatly here as moneyflow from other pharma that do price gouge will come into CXR.  As investors educate themselves more it will happen.  CXR is completely undervalued here.  A joke.  
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities